1. The role of pyruvate carboxylation in the net synthesis of tricarboxylic acid-cycle intermediates during acetate metabolism was studied in isolated rat hearts perfused with [1-_4Clpyruvate. 2. The incorporation of the '4C label from f 1-'4Clpyruvate into the tricarboxylic acid-cycle intermediates points to a carbon input from pyruvate via enzymes in addition to pyruvate dehydrogenase and citrate synthase. 3. On addition of acetate, the specific radioactivity of citrate showed an initial maximum at 2 min, with a subsequent decline in labelling. The C-6 of citrate (which is removed in the isocitrate dehydrogenase reaction) and the remainder of the molecule showed differential labelling kinetics, the specific radioactivity of C-6 declining more rapidly. Since this carbon is lost in the isocitrate dehydrogenase reaction, the results are consistent with a rapid inactivation of pyruvate dehydrogenase after the addition of acetate, which was confirmed by measuring the '4CO2 production from [1-14Clpyruvate. 4. The results can be interpreted to show that carboxylation of pyruvate to the C4 compounds of the tricarboxylic acid cycle occurs under conditions necessitating anaplerosis in rat myocardium, although the results do not identify the enzyme involved. 5. The specific radioactivity of tissue lactate was too low to allow it to be used as an indicator of the specific radioactivity of the intracellular pyruvate pool. The specific radioactivity of alanine was three times that of lactate. When the hearts were perfused with [1-'4Cllactate, the specific radioactivity of alanine was 70% of that of pyruvate. The results suggest that a subcompartmentation of lactate and pyruvate occurs in the cytosol.
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Intermediates of the tricarboxylic acid cycle are continuously regenerated by 'anaplerotic' mechanisms (Kornberg, 1966) . Under some conditions net anaplerosis occurs, leading to an increase in the metabolite pool of the tricarboxylic acid cycle. In cardiac muscle in vitro, this occurs upon an increase in the supply of external substrates such as glucose (Garland & Randle, 1964; Safer & Williamson, 1973) , ketone bodies (Bowman, 1966) , propionate (Davis & Quastel, 1964) , pentenoate (Hiltunen, 1978) and acetate (Randle et al., 1970) , and upon aerobic arrest of the heart (Hiltunen & Hassinen, 1977) , and in the brain during ischaemia (Folbergrova et al., 1974) .
Potential anaplerotic pathways include coupled transaminations between aspartate and pyruvate (Davis & Bremer, 1973) , the purine nucleotide cycle (Lowenstein, 1972) , and oxidative deamination of glutamate or carboxylation of pyruvate (Spydevold et al., 1976) . The mechanism of the last reaction has not been identified in the heart, where the activity of pyruvate carboxylase (EC 6.4.1.1) is considered to be low (Scrutton & Utter, 1968) . It has been suggested that reversal of the decarboxylating reaction of malate dehydrogenase (EC 1.1.1.39) may be involved, at least in skeletal muscle (Spydevold et al., 1976) . In the present study metabolic perturbations induced by acetate in the pyruvate-perfused rat heart were employed to investigate the routes by which pyruvate carbon enters the tricarboxylic acid-cycle intermediates. The heart was perfused with pyruvate and the acetate-induced changes in the metabolitelabelling kinetics from [1-14C] (Takala, 1981) 
Heart extracts
At the end of the perfusions the hearts were frozen with aluminium tongs cooled with liquid nitrogen (Wollenberger et al., 1960) . The frozen pulverized sample was extracted with 8% (v/v) HCI04 in 40% (v/v) ethanol, pre-cooled to -200C (Williamson & Corkey, 1969) . Extraction was repeated with 6% (v/v) HC104 and the filtrate neutralized to pH 6 with 3.75 M-K2CO3 containing 0.5 M-triethanolamine hydrochloride.
Metabolite and specific-radioactivity determinations The metabolites were determined by enzymic methods, by measuring the appearance or disappearance of NADH in an Aminco DW-2 dualwavelength spectrophotometer by using an E340-6385 value of 5.33 x 103 litre * mol-' E cm-'. Citrate was measured with citrate lyase (EC 4.1.3.6) (Gruber & M6llering, 1966) , malate essentially by the method of Williamson & Corkey (1969) , glutamate with glutamate dehydrogenase (EC 1.4.1.4) , and aspartate with aspartate aminotransferase (EC 2.6.1.1) and malate dehydrogenase (EC 1.1.1.37) . Lactate was measured enzymically as described by Hohorst (1963) , pyruvate by the method of Bucher et al. (1963) , 2-oxoglutarate as described by Narins & Passonneau (1970) , and alanine as described by Grassl (1970) . CoA and acetyl-CoA were measured with 2-oxoglutarate dehydrogenase and phosphotransacetylase (Tubbs & Garland, 1969) .
After addition of l,mol of the metabolites as a carrier, the metabolites were isolated from the HC104 extracts by ion-exchange chromatography on a Dowex-1 (formate form) column (LaNoue et al., 1970) and eluted in an exponential gradient of formic acid and subsequently with ammonium formate. A 1-2ml sample of the fractions was used for radioactivity determination by liquid-scintillation counting in Bray's (1960) solution. Fractions containing glutamate, aspartate, f,-hydroxybutyrate and lactate, which could not be properly resolved in the Dowex-1 column, were further analysed by ionexchange chromatography on an automatic amino acid analyser. The specific radioactivity of alanine, which was eluted as a single peak from the Dowex-1 (formate form) column, was ascertained by its enzymic interconversion to lactate by alanine aminotransferase, lactate dehydrogenase and an excess of 2-oxoglutarate and NADH. The lactate formed was further purified on a Dowex-1 (formate form) column and its radioactivity determined. The results of the enzymic interconversion demonstrated that 98% of the radioactivity of the first alanine peak was due to alanine. The recovery of the compounds studied was tested by adding known amounts of the radioactive compounds to the HC104 before homogenizing the freeze-clamped heart. Recovery through the complete analytical procedure was 90% for malate, 98% for citrate, 80% for glutamate, 74% for aspartate, and 98% for alanine. Corrections for recovery were applied when calculating the specific radioactivities.
In determining the specific radioactivity of citrate, the citrate/isocitrate fraction was used without further separation into components. This is justifiable, since the isocitrate concentration is only one-tenth of that of citrate (Hiltunen & Hassinen, 1977) and the aconitase reaction is considered to be in equilibrium (England et al., 1967) .
On the Dowex-1 (formate form) column 92% of the radioactivity of the pyruvate substrate was eluted as a single peak, and the elution point of the remainder did not coincide with that of any of the other compounds measured in the present study.
The rate of oxidation of external pyruvate was determined by measuring the specific radioactivity of perfusate bicarbonate. The perfusion effluent was collected in min fractions under heptane. "4CO2 was liberated from the samples by acidification with 2 ml of 10% (w/v) trichloroacetic acid in special vials allowing the collection of CO2 into NCS solution (The Radiochemical Centre), which was effected by an incubation for 1 h with constant shaking. Samples of the influent perfusate were treated similarly and used as controls for the spontaneous decarboxylation of pyruvate, which under these conditions was very slow.
Specific radioactivity of C-6 ofcitrate Citrate was degraded to 2-oxoglutarate and CO2 by coupled enzymic reactions using aconitase (EC 4.2.1.3) and isocitrate dehydrogenase (EC 1.1.1.42) (Williamson & Corkey, 1969) . The reaction was carried out in special vessels equipped with a side arm with an injection port for acidification of the sample with trichloroacetic acid (see below) and with a device for the collection of CO2 on a filter-paper strip impregnated with 0.2ml of NCS solution. The incubation temperature was 37°C. The reaction was started by adding 1.0ml of the sample (neutralized HCl04 extract) to 2.9 ml of a reaction mixture containing 130mM-Tris/HCI, pH 7.4, 197pM-NADP+, 0.69 mM-MgSO4, 0.2 mM-Fe(NH4)2(SO4)2, 2mM-L-cysteine and aconitase (180munits/ml) (Morrison, 1954) . This mixture was first incubated for 1h to allow the activation of aconitase with the concomitant colour change to run into completion, so that the subsequent isocitrate dehydrogenase reaction could be monitored reliably. Thereafter isocitrate dehydrogenase (1.8 units) was added in 0.5 ml of 20mM-Tris/HCI (pH7.4)/0.02% serum albumin, and the mixture was further incubated for 3 h. Next 0.5 ml of 20% (w/v) trichloroacetic acid was added and the CO2 liberated was collected in 0.2ml of Vol. 202 NCS solution during a further incubation for 2h with continuous shaking. The radioactivity of the NCS solution ' was counted in toluene-based scintillant.
The validity of the determinations of the specific radioactivity was tested with 6-"4C-labelled citrate. The recovery of the label from [6-'4C]citrate was 90-92% and the aconitase plus isocitrate dehydrogenase reactions were complete as observed by spectrophotometric monitoring of the NADPH absorbance.
Results and discussion Rationale ofthe experiment
The label of [1-_4C]pyruvate can enter the tricarboxylic acid cycle directly by the synthesis of C4 such as malate or oxaloacetate (via the decarboxylating malate dehydrogenase reaction or pyruvate carboxylase). Since the oxaloacetate concentration is so low that its specific radioactivity could not be determined with sufficient accuracy, only that of malate was determined here. This was justified, since the malate dehydrogenase reaction is considered to be in equilibrium in the heart (Opie & Owen, 1975) . The carbon atoms of oxaloacetate and malate are retained in C-1, -2, -3 and -6 of citrate. When the label enters through the carboxylation of [1-"4C]-pyruvate and randomization of the label occurs in the fumarate hydratase reactfon, one-half of the label should be in C-6 of the citrate and one-half in the remainder of the molecule. The label of C-6 of citrate is lost in the isocitrate dehydrogenase reaction and its reversal through the mediation of the nearequilibrium of the aconitase reaction. If the label entered the citrate through the prior formation of labelled CO2 at the pyruvate dehydrogenase step, the label would be found only in C-6 of citrate, owing to the reversal of the isocitrate dehydrogenase and aconitase reactions. In heart muscle the rate of formation of oxaloacetate from citrate via citrate lyase is extremely low (Srere, 1959; Nuutinen et al., 198 1a) , so that appreciable labelling of malate should not occur by this mechanism. The specific radioactivity of CO2 was found to be so low that its contribution in the direct carboxylation of [1-"4CI-pyruvate need not be taken into account. Lactate and alanine External [1-14Clpyruvate was used as the source of the label, but for quantitative determination of the rate of incorporation of pyruvate carbon into the metabolites the specific radioactivity of the intracellular pyruvate must be known. The specific radioactivity of lactate was determined for use as an estimate of the specific radioactivity of the intracellular pyruvate pool, but was too low. The specific radioactivity of alanine was 3 times that of lactate (Figs. 1 and 2) and reached 31% of that of pyruvate in the influent perfusion fluid. It has previously been thought that lactate can act as an indicator of intracellular pyruvate labelling because of the high activity of the cytosolic lactate dehydrogenase (Scholz et al., 1978) . The present results are not compatible with a near-equilibrium between total myocardial lactate and external pyruvate. Because both lactate and alanine become labelled via intracellular pyruvate, a difference between the specific radioactivities of lactate and alanine is not compatible with one cellular pyruvate pool only. The data rather suggest that two cytosolic pyruvate pools exist.
To test further the principle of two intracellular pyruvate pools, the hearts were also perfused with [1-14C] These findings suggest two compartments of pyruvate, lactate and alanine: a 'peripheral' pool, which communicates with extracellular lactate, and a 'glycolytic' pool, which receives most of the lactate from glycolysis. The 'glycolytic' pyruvate pool has a through-flow from glycolysis, and the lactate dehydrogenase reaction is mainly confined to this compartment. If we also bear in mind that the cardiac lactate dehydrogenase reaction is not necessarily in equilibrium (Kaplan & Everse, 1972; Nuutinen et al., 1981b) , the model would fit the experimental data, i.e. label from external pyruvate equilibrates better with alanine than with lactate, as the 'glycolytic' pyruvate pool is continuously being diluted by glycolytic pyruvate production. When the transfer of label from ['4C lactate is studied, the labelling of alanine shows some lag compared with that of pyruvate. Some earlier reports also indicate cytosolic compartmentation of pyruvate (Mowbray & Ottaway, 1973) , and there is evidence of cytosolic subcompartmentation of glycolytic enzymes in rat heart (Jarvie & Ottaway, 1975) .
Aspartate
The myocardial aspartate content (Fig. 3) did not change significantly during the first 5 min after the start of the acetate infusion. During acetate perfusion the specific radioactivity of aspartate approached that of malate, but, in hearts perfused with pyruvate only, the specific radioactivity of aspartate was only half of that of malate. The reason might be that under these conditions the oxaloacetate concentration is very low (Hiltunen & Hassinen, 1977) compared with the Km of aspartate aminotransferase for oxaloacetate (Henson & Cleland, 1964) . The data are in accord with the findings of Randle et al. (1970) , indicating that the label equilibration between malate and aspartate is not complete. Anaplerosis by means of a coupled reaction of the aspartate aminotransferase and alanine aminotransferase reactions (Davis & Bremer, 1973) should result in a decrease in tissue content of aspartate and a stoichiometric increase in the alanine content. The large size of the aspartate pool and its small percentage changes (Fig. 3) made estimation of stoichiometric relations difficult, but the alanine concentration increased slightly during the first 2min. The labelling of aspartate, however, indicates that pyruvate carboxylation, with the formation of C4 compounds, does occur.
Malate
During acetate perfusion the malate concentration increased in 10min by 35% (Fig. 4) lead to the labelling of C-I and C-4 of oxaloacetate and malate. A further possibility is the citrate lyase reaction, by which label incorporated from bicarbonate to C-6 of isocitrate and citrate by reversal of the isocitrate dehydrogenase (and aconitase) reaction can reach the malate. The activity of citrate lyase is low in the heart, however (Srere, 1959) . The specific radioactivity of malate reaches a maximum at 2 min (Fig. 4) . This rapid label incorporation could be explained by a short initial burst of pyruvate carboxylation, which is known to be regulated by acetyl-CoA (Utter & Scrutton, 1969) . Measurements of the myocardial CoA and acetyl-CoA concentrations indicate that the changes in the concentrations of these effectors are sufficiently fast to explain a rapid activation of pyruvate carboxylase. The tissue acetyl-CoA concentration shows a rapid but transient increase, the maximum occurring at 2min after the onset of perfusion with acetate plus pyruvate. The changes in the CoA concentration are reciprocal to those in acetyl-CoA (Fig. 5) . These changes are reminiscent of those observed after acetate addition only (Randle et al., 1970) , but here they are accentuated, probably owing to the initially high acetyl-CoA production by pyruvate oxidation and a rapid acetate-induced inhibition of pyruvate dehydrogenase, which was evident when the 14C02 production from 11-'4C1-pyruvate was measured. The rate of pyruvate decarboxylation was inhibited by 88% 2min after the addition of acetate, and 1 min later the inhibition was 90% (Fig. 6 ). In addition to the possible decline in the pyruvate carboxylase activity after an initial burst suggested by the changes in the acetyl-CoA concentration, another mechanism could contribute to the decline in the specific radioactivity of malate after the maximum at 2 min, i.e. the slow increase in the size of the malate pool (Fig. 4) reshuffling of carbon between the tricarboxylic acid-cycle intermediates. When [1-'4Clpyruvate was added to the perfusate 10min after the beginning of the perfusion with pyruvate + acetate, the labelling of malate over the next 10min reached about 60% of that observed (Fig. 4) 10 min after the start of the acetate perfusion. The data indicate that considerable pyruvate carboxylation also occurs under conditions in which the tricarboxylic acid-cycle metabolite concentrations do not change, and that higher steady-state concentrations of the cycle intermediates necessitate higher anaplerotic fluxes, probably owing to their higher rates of disposal.
Citrate
The increase in the citrate concentration continued for 10min after the addition of acetate to the perfusion medium. Simultaneously, 14C-labelling of citrate occurred, which, compared with the perfusions without acetate, was faster during the initial 2min (Fig. 7) . In hearts perfused with acetate, the specific radioactivity of C-6 was lower than that of the remainder of the molecule (C-1-C-5), which can be treated as a unit (Fig. 8) . After an initial maximum, the specific radioactivity of C-6 declined, probably because of inhibition of pyruvate dehydrogenase and a decrease of the radioactivity of bicarbonate. Because of the high rates of isocitrate dehydrogenase and its reversal and the near-equilibrium of the aconitase reaction, the radioactivity of C-6 of citrate should follow that of bicarbonate, reaching 50-80% of the specific radioactivity of the latter (Randle et al., 1970; Nuutinen et al., 1981a) . In the absence of acetate, the specific radioactivity of C-6 of citrate was approximately the same as that of bicarbonate (Fig. 6) . In its presence the specific radioactivity of C-6 of citrate was about three times that of bicarbonate. This indicates that under conditions of a high anaplerotic rate the equilibration of label through the aconitase and isocitrate dehydrogenase reactions is not complete. In the remainder of the citrate molecule the label is higher in the acetate-perfused hearts (Fig. 8b) . The label content of C-1-C-5 of citrate is more than half of that of malate, which could be taken as an indication of a compartmentation of malate, the synthesis of citrate being from a pool of higher specific radioactivity.
One factor contributing to the labelling of oxaloacetate, malate and citrate is the tricarboxylic acid-cycle flux, the rate of which shows no fixed relationship to anaplerosis (Nuutinen et al., 1981 a) . Any decrease in this flux should result in an increase in the specific radioactivity of the C4 intermediates, and also in an increased loss of label on the reversal of the isocitrate dehydrogenase and aconitase reaction. Oxygen consumption decreases transiently by 17% on commencement of the acetate perfusion and returns to the control values 3min after the beginning of acetate perfusion. These findings are reminiscent of those of Randle et al. (1970) obtained in the absence of pyruvate (Fig. 9) . Changes in the same direction as in the oxygen consumption must occur in the tricarboxylic acid-cycle flux, which are then in accord with the data on the labelling of malate and C-1-C-5 of citrate. The reason for the transient decrease in the oxygen consumption remains to be identified. This phenomenon occurs concomitantly with an increase in the coronary flow, and a decrease in the beating frequency and systolic intraventricular pressure. These changes in the mechanical performance and coronary circulation could be linked to a derangement of the energy metabolism because of an accumulation of AMP (Randle et al., 1970) , which, owing to the location of acetyl-CoA synthetase, is confined to the intramitochondrial space (Aas, 1971) . The mitochondrial AMP is not accessible to the cytosolic adenylate kinase (Brdiczka et al., 1968) and this may lead to an interference with the recycling of ATP. The latter could also influence the cytosolic AMP concentration, and could then increase the coronary flow by a breakdown of AMP to adenosine (Berne, 1963) .
2-Oxoglutarate and glutamate
The temporal pattern of changes in the 2-oxoglutarate concentration was reminiscent of those observed in malate. The 2-oxoglutarate concentration decreased temporarily at the onset of the acetate perfusion. This may indicate differential fluxes in the two spans of the tricarboxylic acid cycle, i.e. from oxaloacetate to 2-oxoglutarate and from 2-oxoglutarate to oxaloacetate, probably owing to a perturbation of the near-equilibrium of the aspartate aminotransferase reaction.
The total radioactivity of 2-oxoglutarate isolated from the tissue was so low that its specific radioactivity was not determined. The specific radioactivity of glutamate (Fig. 10) reached a value about one-half of that of the C-1-C-S moiety of citrate. A similar ratio between the specific radioactivities of 2-oxoglutarate and glutamate has been observed previously (Nuutinen et al., 1981) . Label incorporation was greatly enhanced by perfusion with acetate in addition of pyruvate, and this enhancement was greater than the enhancement of labelling of the tricarboxylic acid-cycle intermediates. An explanation of this could be the large pool size of glutamate, which then operates as a sink for the label of the cycle intermediates, thereby decreasing their specific radioactivity.
Succinate
No measurable label incorporation into succinate was detected. This is in accordance with the known properties of the stereochemistry and mechanisms of the reactions of the tricarboxylic acid cycle. Since some label was found in fumarate (results not shown), the results indicate that the reversal of the succinate dehydrogenase reaction is negligible.
This can be also reconciled with the observation that the rate of fumarate reduction by isolated mammalian succinate dehydrogenase is only a few per cent of the forward reaction (Singer et al., 1973 pyruvate. In the presence of lactate the metabolite pool sizes of the tricarboxylic acid cycle increased on addition of acetate in a similar manner to that described above for acetate plus pyruvate.
Conclusions
The labelling kinetics of the tricarboxylic acidcycle intermediates during acetate-induced anaplerosis indicates that carboxylation of pyruvate is involved, and that surprisingly rapid activation of the pyruvate-carboxylating pathways occurs on the stimulus of anaplerosis, although the present data do not positively identify the enzyme involved. It has been shown, however, that measurable activity of pyruvate carboxylase (2.2 nmol * min-* mg-1 of protein) can be detected in rat heart mitochondria (Davis et al., 1980) . This value is equivalent to 1.36,pmol *min-l* g-dry wt. of heart, with a myocardial mitochondrial protein content of 80mg. g-' wet wt. (Kinnula & Hassinen, 1977 ) and a wet-weight/dry-weight ratio of 7.7. This activity is higher than is needed for the observed accumulation of tricarboxylic acid-cycle intermediates plus aspartate and glutamate, which was 0.98,umol. min-1 g-' dry wt. during the first 2 min. The observed total incorporation of radioactivity into these compounds was 54 000d.p.m. * g-I dry wt. within 2 min, which is equivalent to 0.27,umol. min-' g-dry wt. calculated on the basis of perfusate pyruvate specific radioactivity, but 5.4,umol-min-1'g-1 dry wt. when the mean specific radioactivity of alanine during the first 2min is taken to represent the intracellular pyruvate specific radioactivity. The [1-'4Cllactate-perfusion data indicate that alanine reaches 35% of the specific radioactivity of pyruvate in 2min, so that a more accurate estimate of pyruvate incorporation would be 1.9 umol min-' g-dry wt. This value, within experimental error, is in accord with the enzyme activity reported in vitro and the observed anaplerotic rate. A more exact estimate of the rate of pyruvate incorporation can only be obtained by computer modelling of the metabolic network involved (Nuutinen et al., 1981 a) . The malic enzymes are able in principle to catalyse the carboxylation of pyruvate. The NAD(P)-linked enzyme will catalyse a reversible reaction, however (Lin & Davis, 1974) , and its activity in the rat heart is very low (Nagel et al., 1980) . NADP+-dependent malic enzyme exists in rat heart, but the reversal of the reaction proceeds at very high concentrations of bicarbonate (200mM) and high concentrations of pyruvate (50mM), and even then the reverse activity is only 6% of the forward reaction. In accordance with this, it has been found that the mitochondrial malic enzyme operates in the disposal of the tricarboxylic acidcycle intermediates (Hiltunen & Davis, 1981) .
Thus the present data corroborate the functioning of pyruvate carboxylation in cardiac muscle, previously suggested to occur on the basis of data on enzyme activities in vitro.
